The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1203
February 28, 2005
View Complete Issue         Table of Contents 2019 
Eszopiclone (Lunesta), a New Hypnotic
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Eszopiclone (Lunesta), a New Hypnotic
February 28, 2005 (Issue: 1203)
Eszopiclone (Lunesta - Sepracor), a benzodiazepine-like drug, has been approved by the FDA for oral treatment of insomnia. It is the S-isomer of zopiclone (Imovane, and others in Canada), which has been available in other countries for almost 20...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Eszopiclone (Lunesta), a New Hypnotic
Article code: 1203a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.